R&D JP Morgan 2024 – Frank Gleeson In this brief dispatch from JP Morgan, Editor in Chief Jonah Comstock grabs a few minutes with Frank Gleeson, CEO of Satellos Bioscience.
News Lundbeck drops in on epilepsy drug with $2.6bn Longboard bid Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
